Top Banner
Review CALL FOR PAPERS Neurobiology of Deep Brain Stimulation Network effects of deep brain stimulation Ahmad Alhourani, 1 Michael M. McDowell, 1 Michael J. Randazzo, 1 Thomas A. Wozny, 1 Efstathios D. Kondylis, 1 Witold J. Lipski, 1 Sarah Beck, 1 Jordan F. Karp, 2 Avniel S. Ghuman, 1,3 and R. Mark Richardson 1,3 1 Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania; 2 Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania; and 3 Center for the Neural Basis of Cognition, Pittsburgh, Pennsylvania Submitted 16 March 2015; accepted in final form 10 August 2015 Alhourani A, McDowell MM, Randazzo MJ, Wozny TA, Kondylis ED, Lipski WJ, Beck S, Karp JF, Ghuman AS, Richardson RM. Network effects of deep brain stimulation. J Neurophysiol 114: 2105–2117, 2015. First published August 12, 2015; doi:10.1152/jn.00275.2015.—The ability to differentially alter specific brain functions via deep brain stimulation (DBS) represents a monumental advance in clinical neuro- science, as well as within medicine as a whole. Despite the efficacy of DBS in the treatment of movement disorders, for which it is often the gold-standard therapy when medical management becomes inadequate, the mechanisms through which DBS in various brain targets produces therapeutic effects is still not well understood. This limited knowledge is a barrier to improving efficacy and reducing side effects in clinical brain stimulation. A field of study related to assessing the network effects of DBS is gradually emerging that promises to reveal aspects of the underlying pathophysiology of various brain disorders and their response to DBS that will be critical to advancing the field. This review summarizes the nascent literature related to network effects of DBS measured by cerebral blood flow and metabolic imaging, functional imaging, and electrophysiology (scalp and intracranial electroencephalography and magnetoencepha- lography) in order to establish a framework for future studies. deep brain stimulation; electrocorticography; magnetoencephalography DEEP BRAIN STIMULATION (DBS) provides a unique opportunity for further understanding of healthy and aberrant human brain function. DBS is the only paradigm in which specific deep brain regions may be manipulated through focal electrical stimulation while simultaneously recording brain activity. An emerging field of study has begun to elucidate how different DBS targets modulate network activity in connected brain regions. The field of DBS has experienced substantial growth since its reestablishment in the modern era by Benabid nearly 30 years ago (Benabid et al. 1987). A wealth of clinical evidence has established a role for DBS in the management of move- ment disorders, including Parkinson’s disease (PD) (Limousin et al. 1998b), essential tremor (ET) (Miocinovic et al. 2013), and dystonia (Coubes et al. 2004). More recently, the use of DBS has expanded into the field of neuropsychiatry, with investigators exploring the potential of DBS to produce clinical improvement for patients with major depressive disorder (MDD) (Holtzheimer and Mayberg 2012), obsessive-compul- sive disorder (OCD) (Mallet et al. 2008), Tourette syndrome (Ackermans et al. 2011), neuropathic pain (Pereira and Aziz 2014), and addiction (Alba-Ferrara et al. 2014). Epilepsy also is an important emerging indication for DBS (Bergey et al. 2015; Salanova et al. 2015). In parallel, the technology itself is improving, with closed-loop systems and novel electrode ar- rays currently under development that are expected to improve the efficacy of DBS (McIntyre et al. 2015). Despite the fact that DBS has been investigated for over 20 different indications, with targets in nearly 40 distinct brain regions (Hariz et al. 2013), the mechanisms through which DBS modulates brain networks and the effects of focal stim- ulation on both local and distributed brain functions are not yet clear. Several critical questions remain to be answered in the context of each target and therapeutic application: 1) What are the most therapeutically effective target structures, 2) What are the relevant neurophysiological effects of DBS on those struc- tures, and 3) How do these effects modulate the activation of diffuse functional networks to produce desired or undesired behavioral changes? Brain regions targeted by DBS are vari- ably composed of neuronal somata making up the gray matter in the vicinity of the stimulated electrode contact, axonal projections both through and adjacent to the target, or primarily white matter tracts themselves. The complexity of determining the neurobiological mechanisms of DBS therapy is com- Address for reprint requests and other correspondence: R. M. Richardson, Brain Modulation Laboratory, Dept. of Neurological Surgery, Univ. of Pitts- burgh Medical Center, 200 Lothrop St., Suite B400, Pittsburgh, PA 15213 (e-mail: [email protected]). J Neurophysiol 114: 2105–2117, 2015. First published August 12, 2015; doi:10.1152/jn.00275.2015. 2105 0022-3077/15 Copyright © 2015 the American Physiological Society www.jn.org
13

Network effects of deep brain stimulation

Dec 07, 2022

Download

Documents

Akhmad Fauzi
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Network effects of deep brain stimulation
Ahmad Alhourani,1 Michael M. McDowell,1 Michael J. Randazzo,1 Thomas A. Wozny,1
Efstathios D. Kondylis,1 Witold J. Lipski,1 Sarah Beck,1 Jordan F. Karp,2 Avniel S. Ghuman,1,3
and R. Mark Richardson1,3
1Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania; 2Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania; and 3Center for the Neural Basis of Cognition, Pittsburgh, Pennsylvania
Submitted 16 March 2015; accepted in final form 10 August 2015
Alhourani A, McDowell MM, Randazzo MJ, Wozny TA, Kondylis ED, Lipski WJ, Beck S, Karp JF, Ghuman AS, Richardson RM. Network effects of deep brain stimulation. J Neurophysiol 114: 2105–2117, 2015. First published August 12, 2015; doi:10.1152/jn.00275.2015.—The ability to differentially alter specific brain functions via deep brain stimulation (DBS) represents a monumental advance in clinical neuro- science, as well as within medicine as a whole. Despite the efficacy of DBS in the treatment of movement disorders, for which it is often the gold-standard therapy when medical management becomes inadequate, the mechanisms through which DBS in various brain targets produces therapeutic effects is still not well understood. This limited knowledge is a barrier to improving efficacy and reducing side effects in clinical brain stimulation. A field of study related to assessing the network effects of DBS is gradually emerging that promises to reveal aspects of the underlying pathophysiology of various brain disorders and their response to DBS that will be critical to advancing the field. This review summarizes the nascent literature related to network effects of DBS measured by cerebral blood flow and metabolic imaging, functional imaging, and electrophysiology (scalp and intracranial electroencephalography and magnetoencepha- lography) in order to establish a framework for future studies.
deep brain stimulation; electrocorticography; magnetoencephalography
DEEP BRAIN STIMULATION (DBS) provides a unique opportunity for further understanding of healthy and aberrant human brain function. DBS is the only paradigm in which specific deep brain regions may be manipulated through focal electrical stimulation while simultaneously recording brain activity. An emerging field of study has begun to elucidate how different DBS targets modulate network activity in connected brain regions.
The field of DBS has experienced substantial growth since its reestablishment in the modern era by Benabid nearly 30 years ago (Benabid et al. 1987). A wealth of clinical evidence has established a role for DBS in the management of move- ment disorders, including Parkinson’s disease (PD) (Limousin et al. 1998b), essential tremor (ET) (Miocinovic et al. 2013), and dystonia (Coubes et al. 2004). More recently, the use of DBS has expanded into the field of neuropsychiatry, with investigators exploring the potential of DBS to produce clinical improvement for patients with major depressive disorder (MDD) (Holtzheimer and Mayberg 2012), obsessive-compul- sive disorder (OCD) (Mallet et al. 2008), Tourette syndrome
(Ackermans et al. 2011), neuropathic pain (Pereira and Aziz 2014), and addiction (Alba-Ferrara et al. 2014). Epilepsy also is an important emerging indication for DBS (Bergey et al. 2015; Salanova et al. 2015). In parallel, the technology itself is improving, with closed-loop systems and novel electrode ar- rays currently under development that are expected to improve the efficacy of DBS (McIntyre et al. 2015).
Despite the fact that DBS has been investigated for over 20 different indications, with targets in nearly 40 distinct brain regions (Hariz et al. 2013), the mechanisms through which DBS modulates brain networks and the effects of focal stim- ulation on both local and distributed brain functions are not yet clear. Several critical questions remain to be answered in the context of each target and therapeutic application: 1) What are the most therapeutically effective target structures, 2) What are the relevant neurophysiological effects of DBS on those struc- tures, and 3) How do these effects modulate the activation of diffuse functional networks to produce desired or undesired behavioral changes? Brain regions targeted by DBS are vari- ably composed of neuronal somata making up the gray matter in the vicinity of the stimulated electrode contact, axonal projections both through and adjacent to the target, or primarily white matter tracts themselves. The complexity of determining the neurobiological mechanisms of DBS therapy is com-
Address for reprint requests and other correspondence: R. M. Richardson, Brain Modulation Laboratory, Dept. of Neurological Surgery, Univ. of Pitts- burgh Medical Center, 200 Lothrop St., Suite B400, Pittsburgh, PA 15213 (e-mail: [email protected]).
J Neurophysiol 114: 2105–2117, 2015. First published August 12, 2015; doi:10.1152/jn.00275.2015.
21050022-3077/15 Copyright © 2015 the American Physiological Societywww.jn.org
pounded by the fact that target structures act as relay nodes in larger networks, which are perturbed by the reverberating effects of stimulation (McIntyre et al. 2004; McIntyre and Hahn 2010; Vitek 2002). An initial explanation for the effects of high-frequency DBS was that stimulation inhibits the tar- geted structure, thereby producing a functional lesion during (Filali et al. 2004) and after (Beurrier et al. 2001) stimulation. Alternate hypotheses have proposed that activation of the target or induction of long-term synaptic plasticity alters ex- citability (Kombian et al. 2000). Furthermore, given the oscil- latory nature of the train of stimulation pulses employed in DBS, its effects can alter the rhythmic interaction of targeted networks, effectively altering information flow without clearly inhibiting or activating neural tissue (Chiken and Nambu 2014). For instance, axonal and synaptic failures induced by short-term depression following axonal excitation by DBS have been hypothesized to suppress information transfer (Rosenbaum et al. 2014). Finally, DBS may induce a regular rhythm driven by high-frequency stimulation that overrides the pathological rhythm present in the target area (Garcia et al. 2005).
This review describes the cortical effects of DBS primarily in networks linked with the 1) subthalamic nucleus (STN), 2) globus pallidus internus (GPi), 3) thalamus, and 4) nucleus accumbens (NAc) (Fig. 1). We have integrated reports from the functional magnetic resonance imaging (fMRI), positron emis- sion tomography (PET), electroencephalography (EEG), elec- trocorticography (ECoG), and magnetoencephalography (MEG) literature. Each of these techniques offers different advantages and has unique limitations, which must be appre- ciated in order to interpret the findings. For instance, functional and metabolic imaging offer spatial resolution superior to scalp EEG, allow for measuring activity in subcortical structures, and are not affected by the electrical artifact of stimulation, but the temporal resolution of network activity is limited and static. MEG and ECoG can demonstrate spectral changes at the cortical level with high temporal and spatial resolution but require that the effect of electrical stimulation is filtered out. These data are reviewed in the context of current hypotheses related to the mechanisms of action of DBS on motor, cogni- tive, and neuropsychiatric functions.
Network Effects of Subthalamic Nucleus Stimulation
Although over 100,000 patients have undergone DBS im- plantation for various indications, the majority of our experi- ence with recording network effects during DBS comes from STN stimulation for the treatment of PD. Unless otherwise stated, the studies reviewed in the STN sections below involve DBS of the sensorimotor territory of the STN for PD. A current hypothesis for the therapeutic effects of STN DBS in PD is that STN stimulation decreases pathological synchronization in the beta frequency band between STN and primary motor cortex (PMC). This pathological synchronization is disrupted by both STN stimulation and dopaminergic therapies and has been correlated with clinical improvement (de Hemptinne et al. 2013; Oswal et al. 2013). However, various associations with disinhibition in cognition and mood have also been docu- mented in patients after surgery (Castrioto et al. 2014). These changes indicate stimulation effects extending beyond local targets in sensorimotor STN. These effects can be explained anatomically given the known involvement of the STN in multiple circuits connecting the basal ganglia to the cortical regions that regulate motor, cognitive, and emotional behavior (Alexander et al. 1986). Furthermore, these diverse effects can be attributed to the systematic and random procedural errors leading to minor location inaccuracies but with substantial neurophysiological effects (Tsai et al. 2007). The mechanisms by which stimulation modulates these brain networks remain controversial and are the subject of active investigation.
STN studies using PET. A substantial amount of work has been accomplished with metabolic imaging using both 18-FDG and [15O]H2O PET (Akatsubo and Akabayashi 2009; Asanuma et al. 2006; Ceballos-Baumann et al. 1999; Chul et al. 2007; Devos et al. 2004; Geday et al. 2009; Haegelen et al. 2010; Haslinger et al. 2005; Hilker et al. 2002, 2004; Karimi et al. 2008; Limousin et al. 1997; Mure et al. 2011; Sestini et al. 2002, 2007; Sidtis et al. 2012; Strafella et al. 2003; Trost et al. 2006), the former measuring glucose metabolism and the latter measuring regional changes in cerebral blood flow (rCBF). The main aim of these studies in STN DBS was to assess motor system function in PD and its relation to treatment by examining cortical metabolic changes induced by DBS during both resting state and simple motor tasks. Considering studies with a minimum of 15 subjects, testing patients off medications and without previous surgeries, a general pattern emerges in a motor network including the PMC, lateral premotor cortex, dorso- lateral prefrontal cortex (DLPFC), supplementary motor area (SMA), and anterior cingulate cortex (ACC). Com- pared with off-stimulation, there is decreased activation in this network at rest during STN DBS. In contrast to the effect of DBS at rest, during self-initiated movement STN DBS is associated with increased metabolism in rostral SMA, ACC, and DLPFC. A prospective study in which 40 PD patients and age-matched control subjects were scanned at rest demonstrated that clinical improvement was associ- ated with perfusion decrements in primary motor and pre- motor cortices. Cerebellar activation increased during stim- ulation, in conjunction with evidence of modulation of a cerebello-thalamo-cortical loop functionally connected to the cortico-basal ganglia motor loop (Cilia et al. 2009). Thus STN DBS appears to differentially affect the resting-state
Fig. 1. Schematic of network modulation by deep brain stimulations (DBS) in 3 major targets. Brain regions modulated by DBS of the subthalamic nucleus (STN; orange), thalamus (red), and nucleus accumbens (yellow) are indicated (in the contralateral hemisphere for visual clarity). S1, primary sensory cortex; M1, primary motor cortex; SMA, supplementary motor area; PMC, premotor cortex; DLPFC, dorsolateral prefrontal cortex; ACC, anterior cingulate cortex; PHG, parahippocampal gyrus.
Review
J Neurophysiol • doi:10.1152/jn.00275.2015 • www.jn.org
network compared with the functional motor network. Part of the discrepancy found among studies recording during movement, however, is also likely attributable to the type of task employed.
Metabolic imaging while subjects perform cognitive tasks has shed some light on the neural bases of cognitive changes reported in DBS. Verbal fluency performance during stimula- tion has been shown to correlate with activation of the left inferior frontal gyrus, left inferior temporal gyrus, left DLPFC, and ACC (Cilia et al. 2007; Kalbe et al. 2009; Schroeder et al. 2003). STN DBS effects on the DLPFC and ACC have also been investigated in relation to conflict monitoring using the Stroop task (Schroeder et al. 2002), random number generation (Thobois et al. 2007), and working memory and response inhibition (Campbell et al. 2008). In all of these studies, a decrease in regional activity of those regions induced by DBS correlated with the impairments in the corresponding cognitive function being assayed in the former two studies, while the opposite effect was observed in the latter study. Notably, a specific pattern of activation at rest, characterized by metabolic reductions in frontal and parietal association areas and relative increases in the cerebellar vermis and dentate nuclei, has separately been shown to predict memory performance, visu- ospatial function, and perceptual motor speed but was not significantly altered by antiparkinsonian medications or DBS (Huang et al. 2007). These findings may suggest a discrepancy between DBS affects during task-related epochs compared with epochs in which a subject is not engaged in a task.
Modulation of key parts of the limbic circuit has been demonstrated in a large series of patients; however, no resul- tant cognitive improvement was detected on neuropsycholog- ical testing except modest improvements in a card-sorting task (Le Jeune et al. 2010). This result is potentially confounded because patients were tested who were still on medication in addition to DBS. In a study of apathy following DBS, positive correlations were observed between apathy scores and in- creases in glucose metabolism, especially in the right frontal middle gyrus and inferior frontal gyrus (Le Jeune et al. 2009). Finally, DBS-induced deactivation in the fusiform gyrus has been correlated with the impairment of facial expression rec- ognition (Geday et al. 2006).
STN DBS has also been used as a treatment for OCD, with electrode placement in the limbic territory of the STN. A PET study showed that this therapy resulted in a decrease in me- tabolism of the left cingulate and medial gyrus of the left frontal lobe. Clinical improvement was correlated with a de- crease of metabolic activity in the orbitofrontal cortex (OFC)- ventral medial prefrontal region in ON vs. OFF conditions (Le Jeune et al. 2010).
STN studies using functional magnetic resonance imaging. The application of fMRI to investigation of DBS has been hindered by concerns regarding safety (Finelli et al. 2002; Georgi et al. 2004; Shrivastava et al. 2012) and by significant artifacts in the acquired images, although there is evidence that its use under strict guidelines may be safe (Carmichael et al. 2007). Because of these safety concerns, this imaging modality remains underutilized, with few studies published using fMRI during active stimulation and limited to the use of 1.5-T scanners (Arantes et al. 2006; Hesselmann et al. 2004; Jech et al. 2001; Kahan et al. 2012, 2014; Stefurak et al. 2003) except for Phillips et al. (2006), where a 3-T scanner was used. Each
of these patient cohorts did not exceed five patients, outside of the work by Kahan and colleagues. The reader also is referred to Boertien and colleagues (Boertien et al. 2011) for a recent extensive review of functional imaging in STN DBS.
Nonetheless, initial fMRI studies of DBS effects at rest essentially have corroborated earlier metabolic imaging find- ings. In addition, Kahan and colleagues studied the effects of DBS on the motor network directly by using dynamic causal modeling in 10 subjects (Kahan et al. 2014). Their findings suggest that the therapeutic effects of DBS arise from strength- ening the cortico-striatal, direct, and thalamocortical pathways while disrupting all afferent and efferent inputs to the STN. Disruption or weakening of incoming and outgoing connectiv- ity with STN DBS is beneficial when it involves the overly connected motor network. However, this interference with other networks also may explain side effects related to cogni- tive functions for which the STN is an important network node. While it offers potential new insight into DBS effects, this model lacks some elements of the actual human network (like the globus pallidus) and still requires validation on a larger data set.
STN studies using EEG and ECoG. During rest, STN DBS has been shown via scalp EEG to induce a broadband decrease in spectral power in frontocentral electrodes (Jech et al. 2006) and a widespread decrease of coherence predominantly in the beta frequency band (Hotton et al. 2005). During movement preparation, STN stimulation was shown to partially restore normal patterns of cortical activation by decreasing abnormal desynchronization prior to movement onset over the bilateral frontocentral regions (Devos et al. 2004), suggesting increased activation of the premotor cortex by DBS.
In addition to motor effects, STN stimulation can have effects on the processing of sensory information. Cortical encoding of sensory stimuli has often been analyzed with event-related potentials (ERPs), which represent time-locked cortical neuronal population activity in response to a certain stimulus. The synchronization of this activity depends on several factors including the intrinsic membrane properties of the neurons and the state of their local and global networks (Pfurtscheller and Lopes da Silva 1999). The downstream effects of stimulation on these factors can be seen in the generation of ERPs and possibly extrapolated to the cognitive processes related to the stimulus used. This paradigm was used in several studies in the PD population listed in Table 1. Cortical sensory ERPs typically were reduced or unchanged by stimulation. Thus stimulation may interfere with neuronal synchronization, potentially disrupting the phase reorganiza- tion needed for the generation of an ERP (Sayers et al. 1974), but this effect on sensory processing, when present, appears to be weak. Stimulation generally has not demonstrated an effect on ERP latency. Only one study (Selzler et al. 2013) has reported a slowing in latency to match that of the control group, although task performance did not change. The lack of correlation between task performance and ERP generation suggests that more sophisticated measures are required to assess the effects of DBS, a point directly demonstrated by Swann et al. (2011), where time-frequency plots showed greater sensitivity to the effects of DBS whereas ERPs were insensitive to these effects. This implies that DBS affects oscillatory dynamics not well captured by ERPs. This concern, in addition to the difficulty associated with removing the
Review
2107NETWORK EFFECTS OF DBS
J Neurophysiol • doi:10.1152/jn.00275.2015 • www.jn.org
stimulation artifact in EEG, has led some to turn to MEG to study the cortical effects of DBS.
Electrical stimulation has a predilection for activating axons in long tracts compared with cell bodies near the source (Nowak and Bullier 1998). This can be captured in subjects as evoked potentials (EPs) time-locked to the stimulation train. The resultant EP demonstrated synchronization of cortical activity with stimulation, where the different parts of the EP were thought to represent different modes of synaptic trans- mission. Both a short latency (8 ms) and a long latency (18 ms) were observed (Ashby et al. 2001; Baker et al. 2002; Eusebio et al. 2009; Kuriakose et al. 2010; Limousin et al. 1998a; MacKinnon et al. 2005; Walker et al. 2012b). The topography of these EPs encompassed frontal and central areas. The timing of the short-latency components is more consistent with antidromic conduction through the corticosub- thalamic projections. The longer latency might represent or- thodromic polysynaptic conduction through the basothalamo- cortical circuit. Of note, Walker and colleagues went further to explore the short-latency component by summating two sets of recordings with reversed anode/cathode pairs in order to sup- press the stimulation artifact. This uncovered a component at a latency of 1 ms, suggesting that the short-latency components seen in previous studies might represent the tail of the wave- form that was obscured by the stimulation artifact. However, a number of these studies only use low-frequency stimulation (5–30 Hz), making interpretation of these results to explain clinical high-frequency stimulation difficult.
Patients with PD often exhibit cognitive dysfunction in addition to classical motor symptoms. An important question is how pathology in brain networks contributes to this dysfunc- tion and how DBS affects these networks. Even in early, untreated PD patients, widespread increases in the amplitude of theta and low alpha rhythms have been observed, with in- creased alpha power in the centroparietal region associated with abnormal perseveration (Stoffers et al. 2007). Separately, STN DBS has been shown to result in a decrease in spectral power in the alpha band (Jech et al. 2006), but whether this normalization of low-frequency activity contributes to cogni- tive improvement is unknown.
On the other hand, impulsivity is a consequence of STN stimulation not seen in patients receiving L-DOPA therapy (Frank et al. 2007; Hälbig et al. 2009). The leading explanation is that stimulation interferes with normal STN inhibition that
withholds actions until a decision threshold is reached, espe- cially during conflict. For instance, during conflict monitoring, DBS has been shown to disrupt the relationship between the level of theta in medial prefrontal cortex and the decision threshold during conflict leading to response speeding (Ca- vanagh et al. 2011). Swann et al. (2011), however, showed that DBS improved response inhibition and linked…